Chinese medicament for treating luekopenia after concurrent chemoradiotherapy
The invention relates to a Chinese medicament for treating luekopenia after concurrent chemoradiotherapy, which consists of the following raw materials by weight: 10 to 12 grams of American ginseng, 10 to 12 grams of fried atractylodes macrocephala Koidz., 30 to 35 grams of astragalus, 12 to 14 gram...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention relates to a Chinese medicament for treating luekopenia after concurrent chemoradiotherapy, which consists of the following raw materials by weight: 10 to 12 grams of American ginseng, 10 to 12 grams of fried atractylodes macrocephala Koidz., 30 to 35 grams of astragalus, 12 to 14 grams of medlar, 8 to 10 grams of malaytea scurfpea fruit, 10 to 12 grams of tangerine peel, 10 to 12 grams of white paeony root, 10 to 13 grams of Chinese angelica, 28 to 33 grams of siberian solomonseal rhizome and 6 to 8 grams of mix-fried licorice. The Chinese medicament of the invention has the characteristics of simple and rational preparation, good curative effects, wide medicinal sources, convenient use, no toxic or side effect, high curative ratio and the overall response rate of over 98 percent. |
|---|